コンパニオンアニマル薬の世界市場2019-2029

LINEで送る

1. Executive Summary

1.1. Global Market Outlook

1.2. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Dynamics

3.1. Macro-Economic Factors

3.2. Drivers

3.2.1. Supply Side Drivers

3.2.2. Demand Side Drivers

3.3. Restraints

3.4. Opportunities

3.5. Trends

4. Market Context

4.1. Market Overview

4.2. Pipeline Products

4.3. PEST Analysis

4.4. Porter’s Five Forces Model

4.5. Regulatory Scenario

4.6. U.S. Animal Healthcare Spending

5. Global Companion Animal Drugs Market Value Analysis 2014-2018 and Forecast, 2019-2029

5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

6. Global Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type

6.1. Introduction / Key Findings

6.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014-2018

6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 – 2029

6.3.1. Antibiotics

6.3.2. Anti-inflammatory

6.3.3. Parasiticides

6.3.4. Heart Worm Products

6.3.5. Behavioral Products

6.3.6. Nutritional Products

6.3.7. Skin Care Products

6.3.8. Vaccines

6.4. Market Attractiveness Analysis By Product Type

7. Global Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 – 2029

7.3.1. Veterinary Hospitals

7.3.2. Veterinary Clinics

7.3.3. Pharmacies and Drug Stores

7.4. Market Attractiveness Analysis By Distribution Channel

8. Global Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029, by Region

8.1. Introduction

8.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018

8.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029

8.3.1. North America

8.3.2. Latin America

8.3.3. Western Europe

8.3.4. Eastern Europe

8.3.5. Asia-Pacific Excluding Japan

8.3.6. Japan

8.3.7. Middle East & Africa

8.4. Market Attractiveness Analysis By Region

9. North America Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

9.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

9.3.1. By Country

9.3.1.1. U.S.

9.3.1.2. Canada

9.3.2. By Product Type

9.3.3. By Distribution Channel

9.4. Market Attractiveness Analysis

9.5. Regional Trends

9.6. Key Impact Analysis

10. Latin America Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

10.3.1. By Country

10.3.1.1. Brazil

10.3.1.2. Mexico

10.3.1.3. Argentina

10.3.1.4. Rest of Latin America

10.3.2. By Product Type

10.3.3. By Distribution Channel

10.4. Market Attractiveness Analysis

10.5. Regional Trends

10.6. Key Impact Analysis

11. Western Europe Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

11.3.1. By Country

11.3.1.1. U.K.

11.3.1.2. France

11.3.1.3. Germany

11.3.1.4. Spain

11.3.1.5. Italy

11.3.1.6. Nordics

11.3.1.7. Benelux

11.3.1.8. Rest of Western Europe

11.3.2. By Product Type

11.3.3. By Distribution Channel

11.4. Market Attractiveness Analysis

11.5. Regional Trends

11.6. Key Impact Analysis

12. Eastern Europe Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

12.3.1. By Country

12.3.1.1. Russia

12.3.1.2. Poland

12.3.1.3. Rest of Eastern Europe

12.3.2. By Product Type

12.3.3. By Distribution Channel

12.4. Market Attractiveness Analysis

12.5. Regional Trends

12.6. Key Impact Analysis

13. Asia-Pacific Excluding Japan (APEJ) Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

13.3.1. By Country

13.3.1.1. China

13.3.1.2. India

13.3.1.3. Australia and NZ

13.3.1.4. ASEAN

13.3.1.5. Rest of Asia Pacific

13.3.2. By Product Type

13.3.3. By Distribution Channel

13.4. Market Attractiveness Analysis

13.5. Regional Trends

13.6. Key Impact Analysis

14. Middle East and Africa Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

14.3.1. By Country

14.3.1.1. GCC Countries

14.3.1.2. South Africa

14.3.1.3. Rest of MEA

14.3.2. By Product Type

14.3.3. By Distribution Channel

14.4. Market Attractiveness Analysis

14.5. Regional Trends

14.6. Key Impact Analysis

15. Japan Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

15.3.1. By Product Type

15.3.2. By Distribution Channel

15.4. Market Attractiveness Analysis

15.5. Regional Trends

15.6. Key Impact Analysis

16. Competition Analysis

16.1. Competition Dashboard

16.2. Competition Deep Dive

16.2.1. Zoetis, Inc.

16.2.1.1. Company Overview

16.2.1.2. Segment Overview

16.2.1.3. ProductOfferings

16.2.1.4. Financial Analysis

16.2.1.5. Key Developments

16.2.1.6. Strategy Overview

16.2.2. Merck & Co, Ltd.

16.2.2.1. Company Overview

16.2.2.2. Segment Overview

16.2.2.3. ProductOfferings

16.2.2.4. Financial Analysis

16.2.2.5. Key Developments

16.2.2.6. Strategy Overview

16.2.3. Bayer AG

16.2.3.1. Company Overview

16.2.3.2. Segment Overview

16.2.3.3. ProductOfferings

16.2.3.4. Financial Analysis

16.2.3.5. Key Developments

16.2.3.6. Strategy Overview

16.2.4. Elanco

16.2.4.1. Company Overview

16.2.4.2. Segment Overview

16.2.4.3. ProductOfferings

16.2.4.4. Financial Analysis

16.2.4.5. Key Developments

16.2.4.6. Strategy Overview

16.2.5. Boehringer Ingelheim GmbH (Merial)

16.2.5.1. Company Overview

16.2.5.2. Segment Overview

16.2.5.3. ProductOfferings

16.2.5.4. Financial Analysis

16.2.5.5. Key Developments

16.2.5.6. Strategy Overview

16.2.6. Virbac Animal Health

16.2.6.1. Company Overview

16.2.6.2. Segment Overview

16.2.6.3. ProductOfferings

16.2.6.4. Financial Analysis

16.2.6.5. Key Developments

16.2.6.6. Strategy Overview

16.2.7. Ceva Santé Animale

16.2.7.1. Company Overview

16.2.7.2. Segment Overview

16.2.7.3. ProductOfferings

16.2.7.4. Financial Analysis

16.2.7.5. Key Developments

16.2.7.6. Strategy Overview

17. Assumptions and Acronyms Used

18. Research Methodology




※当サイトのレポート紹介カバレッジ
■産業:医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域:世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類:市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様